Requests · The University of Texas at Dallas
Pain Free Texas
Priority 2 · one of 4 items in the The University of Texas at Dallas's request for 2028-29 · The item begins on page 82 of the request
This is a request, not an appropriation.
Figures under review. The request states this item's figures in more than one place and they do not agree, or they have not been checked, so none is shown here. See the request itself.
The agency's justification
Arthritis pain, lower back pain, headache disorders and neuropathic pain are leading causes of disability in Texas. All these pain-related disorders are poorly managed by existing therapeutics, leading to significant healthcare burdens and lost productivity costs. The UT Dallas Center for Advanced Pain Studies (CAPS), through the Pain Free Texas initiative, will create next generation treatments for these disorders to defeat the suffering created by the chronic pain and the opioid epidemic . The Center will develop new pain therapeutics by leveraging high impact human-based molecular neuroscience and building the medicinal chemistry and screening infrastructure to translate today’s basic science discoveries into tomorrow’s pain medicines. Investigators in the Center have already developed two new, non-opioid analgesics that are in clinical trials, but much more is possible. The Center will expand its work with the Southwest Transplant Alliance, located in Dallas, to further enhance a unique human neuroscience discovery platform that will serve as an internationally recognized example for the future of neurotherapeutics development. With focused translational biomedical activity, North Texas will transform into an international hub for cures for neurological disorders, attracting scientists and investment from around the world to overcome some of mankind’s most challenging medical problems.
External and internal factors
Additional information for this strategy is available in Schedule 9, Special Item Information.
As marked in the request
- Has an information technology part: No
- Costs anticipated after the two budget years: Yes
- Involves contracts over $50,000: No